Skip to main content

Table 4 Involvement of CDG professionals and families in CT

From: Stakeholders’ views on drug development: the congenital disorders of glycosylation community perspective

 

Professionals

Families

Have you ever been involved (past and present situation) in the development of a CT for CDG?

(n = 46)

Have you ever participated in a CT for CDG?

(n = 82)

Yes

30.4%

23.2%

Yes, currently participating in a CT

N.A.

1.2%

No

69.6%

70.7%

I don’t know

N.A.

4.9%

 

Professionals

Families

Have you involved patients and/or patient representatives in the design of the CT?

(n = 14)

Were you involved in the design of the CT?

(n = 20)

Yes

64.3%

25.0%

No

35.7%

65.0%

No, and I didn’t know patients/participants/families could be involved in the design of a CT

N.A.

10.0%

 

Professionals

Families

Have you informed the patients who participated in the CT about the results?

(n = 14)

Were you informed of the results of the CT in which you have participated?

(n = 20)

Yes

85.7%

35.0%

No, and the trial has already finished

14.3%

25.0%

No, but the trial is still ongoing

35.0%

I don’t know

N.A.

5.0%